Table 2. The death cases and age-standardized mortality rates from pancreatic cancer, as well as their temporal trends by sex and super-region from 1990 to 2019.
| 1990 | 2019 | 1990–2019 | ||||
|---|---|---|---|---|---|---|
| Death No. (95% UI) | ASMR per 100,000 (95% UI) | Death No. (95% UI) | ASMR per 100,000 (95% UI) | EAPC of ASMR (95% CI) | ||
| World | ||||||
| Total | 198050.91 (189328.90, 204762.56) | 5.34 (5.07, 5.52) | 531107.11 (491948.19, 566536.85) | 6.62 (6.11, 7.46) | 0.77(0.73,0.81) | |
| Female | 94739.12 (89322.34, 98183.67) | 4.64 (4.34, 4.82) | 252933.60 (225846.18, 273819.66) | 5.77 (5.15, 6.24) | 0.74(0.71,0.77) | |
| Male | 103311.78 (98381.20, 108763.78) | 6.12 (5.81, 6.42) | 278173.51 (257504.91, 298745.01) | 7.55 (7.00, 8.79) | 0.79(0.74,0.85) | |
| CEEECA | ||||||
| Total | 32988.70 (31723.08, 34386.86) | 7.00 (6.71, 7.29) | 55073.43 (50226.10, 59699.95) | 8.74 (7.97, 9.46) | 0.64(0.51,0.79) | |
| Female | 15977.37 (15051.38, 17212.27) | 5.38 (5.06, 5.81) | 26809.41 (24070.14, 29521.51) | 6.88 (6.20, 7.57) | 0.77(0.64,0.91) | |
| Male | 17011.33 (16566.34, 17902.98) | 9.41 (9.13, 9.93) | 28264.01 (25413.28, 30995.32) | 11.24 (10.12, 12.29) | 0.48(0.32,0.64) | |
| HI | ||||||
| Total | 104195.34 (99468.66, 106572.21) | 8.61 (8.21, 8.84) | 213898.08 (193069.88, 225910.34) | 9.69 (8.90, 16.18) | 0.46(0.43,0.49) | |
| Female | 52715.88 (49243.05, 54405.18) | 7.24 (6.81, 7.46) | 107722.22 (93859.81, 115766.87) | 8.42 (7.54, 8.97) | 0.57(0.54,0.62) | |
| Male | 51479.45 (50107.83, 52332.27) | 10.32 (9.99, 17.51) | 106175.85 (99851.43, 110648.63) | 11.09 (10.46, 11.54) | 0.30(0.27,0.34) | |
| LAC | ||||||
| Total | 9087.30 (8727.73, 9322.18) | 4.09 (3.92, 4.21) | 33958.87 (30743.64, 37037.14) | 5.65 (5.08, 6.19) | 1.03(0.92,1.13) | |
| Female | 4585.69 (4361.41, 4735.44) | 3.95 (3.74, 4.48) | 17823.66 (15894.83, 19649.58) | 5.40 (4.80 5.99) | 0.96(0.83,1.09) | |
| Male | 4501.61 (4359.66, 4625.94) | 4.23 (4.08, 4.35) | 16135.20 (14534.29, 17860.30) | 5.90 (5.29, 6.51) | 1.10(1.01,1.18) | |
| NAME | ||||||
| Total | 4593.98 (3889.31, 5424.33) | 2.84 (2.37, 3.36) | 22277.14 (19357.43, 25691.38) | 5.49 (4.78, 6.31) | 2.42(2.25,2.59) | |
| Female | 1740.74 (1484.94, 2172.28) | 2.22 (1.87, 2.83) | 8869.50 (7453.34, 10280.70) | 4.58 (3.84, 5.28) | 2.56(2.47,2.65) | |
| Male | 2853.23 (2294.88, 3614.75) | 3.44 (2.75, 4.33) | 13407.63 (11668.48, 15494.71) | 6.37 (5.59, 7.33) | 2.32(2.09,2.54) | |
| SA | ||||||
| Total | 7736.11 (6242.63, 9124.88) | 1.52 (1.22, 1.81) | 40012.01 (35017.29, 45582.35) | 3.04 (2.65, 3.45) | 2.41(2.31,2.51) | |
| Female | 2963.57(2378.78, 3791.73) | 1.25 (0.98, 1.62) | 19881.72 (16392.34, 23534.45) | 2.97 (2.43, 3.49) | 3.01(2.88,3.15) | |
| Male | 4772.53 (3597.34, 6102.64) | 1.78 (1.31, 2.25) | 20130.29 (16818.32, 23654.65) | 3.11 (2.60, 3.65) | 1.98(1.92,2.05) | |
| SAEAO | ||||||
| Total | 34369.12 (30550.47, 38437.22) | 3.15 (2.81, 3.48) | 148207.45 (129127.01, 169171.48) | 5.68 (4.95, 6.47) | 2.22(2.07,2.37) | |
| Female | 14569.83 (12558.02,16560.49) | 2.59 (2.25, 2.94) | 62831.26 (52595.34, 74606.18) | 4.55 (3.81, 5.38) | 1.97(1.83,2.12) | |
| Male | 19799.29 (16680.57, 23304.30) | 3.79 (3.25, 4.42) | 85376.19 (70004.31, 102876.84) | 7.00 (5.80, 8.37) | 2.43(2.27,2.59) | |
| SSA | ||||||
| Total | 5080.32 (4372.88, 5745.31) | 2.61 (2.24, 2.97) | 17680.10 (15687.82, 19936.26) | 4.25 (3.80, 4.74) | 1.61(1.55,1.67) | |
| Female | 2186.01 (1874.44, 2590.67) | 2.24 (1.90, 2.68) | 8995.79 (7838.70, 10286.30) | 4.11 (3.60, 4.64) | 2.08(2.04,2.12) | |
| Male | 2894.31 (2386.34, 3383.68) | 2.99 (2.46, 3.48) | 8684.31 (7541.33, 9891.73) | 4.41 (3.86, 4.97) | 1.22(1.12,1.33) | |
Note: UI Uncertainty Interval; ASMR Age-standardized mortality rate; EAPC Estimated Annual Percentage Change; CI Confidence Interval; CEEECA Central Europe, Eastern Europe, and Central Asia, HI High Income, LAC Latin America and Caribbean, NAME North Africa and Middle East, SA South Asia, SAEAO Southeast Asia, East Asia, and Oceania, SSA Sub-Saharan Africa